Sources: SoftBank's Arm hopes to raise $8B+ at a $50B+ valuation in its US IPO, which is expected later in 2023 after a confidential filing in late April
Context & Ripple Effects
This March report opened the arc that dominated 2023's chip news: SoftBank moving to take Arm public on the confidential Nasdaq filing it made weeks later, seeking $8B-$10B for what was then expected to be the year's largest US IPO. The ask here — more than $8B raised at above $50B — became the floor of a months-long repricing.
First-order effects
- SoftBank gains a public-market exit route for its crown-jewel holding, directly relevant to its persistent problem of trading at roughly a 50% discount to net asset value.
- Arm's licensing-based business gets a standalone currency and disclosure obligations, ending its status as a wholly private asset inside SoftBank's portfolio.
Second-order effects
- The eventual price discovery cut against SoftBank's own marks: after mid-year talk of $60B-$70B targets, the August buyback of a 25% Vision Fund stake at a $64B valuation sat well above where bankers steered the deal toward $50B-$55B.
- A successful large listing resets the reference point for any chip-designer or AI-adjacent issuer weighing a 2023-24 debut, since Arm is the year's bellwether offering.
Third-order effects
- If Arm prices anywhere near the range sketched here, SoftBank's playbook — recycle private holdings into listed equity to close its NAV discount — becomes the template other holding-company structures copy.
- The gap between SoftBank's internal $64B mark and the sub-$55B IPO target foreshadows a recurring tension in AI-era listings: sponsor valuations set in private rounds meeting a colder public book, which the final $47-$51 pricing ultimately resolved near the bottom of even that range.
The trend: AI-chip enthusiasm is reopening the mega-IPO window, but public markets are repricing private AI-era marks downward as sponsors rush to monetize.